I would agree but you are ignoring one important fact, and that...

I would agree but you are ignoring one important fact, and that is that they are opening up a third site and are obviously aware of the hesitance of the potential patients to undertake the trial. It seems they are working hard to fix this.
They also remain committed to complete the trials by the end of the year, it is a clear goal to them. If they fail in this, then there is a cause of concern. That is only 8 months away. Really not a long time for an investor who can see massive gains if all the pieces fall together.

Nothing that is eventually great ever goes the easy path in my experience.